TOIIW

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Ken GriffinCitadel Advisors $-87 ExitQ1 2025 $87 -- --
Ken GriffinCitadel Advisors $-269 TrimQ4 2024 $269 -- --
Ken GriffinCitadel Advisors $-8 TrimQ3 2024 $8 -- --

Trade TOIIW

About The Oncology Institute, Inc.

The Oncology Institute, Inc. operates as a U.S.-based firm, specializing in providing extensive medical oncology services. Its comprehensive offerings encompass direct physician care, integrated on-site infusion and pharmacy services, clinical research initiatives, outpatient stem cell transplant and transfusion programs, and dedicated patient support. The company also oversees and manages specialized programs, including palliative care and stem cell transplants, specifically designed to meet the needs of cancer patients. Established in 2007, its headquarters are located in Cerritos, California.

CEO: Daniel Virnich
IPO Date: Nov 12, 2021

Market Data

Open: $0.1817
High: $0.1817
Low: $0.0544
Volume: 17.4K
52W High: $0.1817
52W Low: $0.0544

Valuation

Market Cap: $5.9M
Enterprise Value: $492M

Financials

Free Cash Flow: $-28M
Revenue: $503M
Net Income: $-61M
Cash: $34M
Debt: $104M

Events

EarningsAug 11

EPS est. -0.065